Variability of Vaginal pH Determination by Patients and Clinicians

References

1. ↵
   Soper DE. Gynecologic complications of bacterial vaginosis: fact or fiction. Am Inf Dis Rep 1999; 1: 393–7.

   OpenUrl
2. ↵
   Wiesenfeld HC, Macio I. The infrequent use of office-based diagnostic tests for vaginitis. Am J Obstet Gynecol 1999; 181: 39–41.

   OpenUrlPubMed
3. ↵
   Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002; 99: 419–25.

   OpenUrlCrossRefPubMedWeb of Science
4. Ferris DG, Dekle C, Litaker MS. Women’s use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996; 42: 595–600.

   OpenUrlPubMedWeb of Science
5. Lipsky M, Waters T. The “Prescription-to-OTC Switch” movement. Arch Fam Med 1999; 8: 297–300.

   OpenUrlCrossRefPubMed
6. ↵
   Sihvo S, Ahonen R, Mikander H, Hemminki, E. Self-medication with vaginal antifungal drugs: physicians’ experiences and women’s utilization patterns. Fam Pract 2000; 17: 145–9.

   OpenUrlAbstract/FREE Full Text
7. ↵
   Petignat P, Hankins C, Walmsley S, Money D, Provencher D. Canadian Women’s HIV Study Group. Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women. Clin Infect Dis 2005; 41: 527–34.

   OpenUrlAbstract/FREE Full Text
8. ↵
   Lack N, West B, Jeffries D, et al. Comparison of non-invasive sampling methods for detection of HPV in rural African women. Sex Transm Infect 2005; 81: 239–41.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol 2004; 15: 863–9.

   OpenUrlAbstract/FREE Full Text
10. Harper DM, Longacre MR, Noll WW, Belloni DR, Cole BF. Factors affecting the detection rate of human papillomavirus. Ann Fam Med 2003; 1: 221–7.

    OpenUrlAbstract/FREE Full Text
11. Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification test. J Clin Microbiol 2003; 41: 4395–9.

    OpenUrlAbstract/FREE Full Text
12. Knox J, Tabrizi SN, Miller P, et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis 2002; 29: 647–54.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed—biologic concordance and women’s preferences. Am J Obstet Gynecol 2002; 186: 365–73.

    OpenUrlCrossRefPubMedWeb of Science
14. Tebb KP, Paukku MH, Pai-Dhungat MR, Gyamfi AA, Shafer MA. Home STI testing: the adolescent female’s opinion. J Adolesc Health 2004; 35: 462–7.

    OpenUrlPubMedWeb of Science
15. Forrest S, McCaffery K, Waller J, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004; 11: 85–8.

    OpenUrlPubMed
16. Richardson E, Sellors JW, Mackinnon S, et al. Prevalence of Chlamydia trachomatis infections and specimen collection preference among women, using self-collected vaginal swabs in community settings. Sex Transm Dis 2003; 30: 880–5.

    OpenUrlCrossRefPubMedWeb of Science
17. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002; 11: 265–75.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Boskey ER, Atherly-Trim SA, O’Campo PJ, Strobino DM, Misra DP. Acceptability of a self-sampling technique to collect vaginal smears for gram stain diagnosis of bacterial vaginosis. Womens Health Issues 2004; 14: 14–8.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Roy S, Cailloutte JC, Faden JS, Roy T, Ramos DE. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device. Infect Dis Obstet Gynecol 2003; 11: 209–16.

    OpenUrlPubMed
20. ↵
    Saling E, Schreiber M, Al-Taie T. A simple, efficient and inexpensive program for preventing prematurity. J Perinat Med 2001; 29: 199–211.

    OpenUrlPubMed
21. ↵
    Kistner RW. Physiology of the vagina in human reproductive medicine. In: Hafez ESE, Evans TN, editors. The human vagina. Vol 2. New York: North-Holland; 1978. p. 109.
22. ↵
    Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis diagnostic criteria and microbial and epidemiologic association. Am J Med 1983; 74: 14–22.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Khandalavala J, Van Geem TA. Evaluating vaginal pH, accuracy of two commercial pH papers in comparison to a hand-held digital pH meter. J Reprod Med 1999; 44: 76–80.

    OpenUrlPubMed
24. ↵
    Roy S, Caillouette JC, Faden JS, Roy T. The role of an over-the-counter vaginal pH self-test device package insert: can subjects learn what the device is for and how to use it?. Am J Obstet Gynecol 2005; 192: 1963–9.

    OpenUrlPubMed
25. ↵
    Lipsky M, Waters T, Sharp L. Impact of vaginal antifungal products on the utilization of health care services: evidence from physician visits. J Am Bd Fam Pract 2000; 13: 178–82.

    OpenUrlAbstract/FREE Full Text
26. ↵
    Lowe N, Ryan-Wenger N. A clinical test of women’s self-diagnosis of genitourinary infections. Clin Nurs Res 2000; 9: 144–60.

    OpenUrlAbstract/FREE Full Text